200 related articles for article (PubMed ID: 17922959)
1. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
Harbige LS; Sharief MK
Br J Nutr; 2007 Oct; 98 Suppl 1():S46-53. PubMed ID: 17922959
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated fatty acids in multiple sclerosis therapy.
Wergeland S; Torkildsen Ø; Bø L; Myhr KM
Acta Neurol Scand Suppl; 2012; (195):70-5. PubMed ID: 23278660
[TBL] [Abstract][Full Text] [Related]
4. Dietary lipids and multiple sclerosis.
Bates D
Ups J Med Sci Suppl; 1990; 48():173-87. PubMed ID: 2077693
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
van Meeteren ME; Teunissen CE; Dijkstra CD; van Tol EA
Eur J Clin Nutr; 2005 Dec; 59(12):1347-61. PubMed ID: 16118655
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined.
Sala-Vila A; Miles EA; Calder PC
Clin Exp Allergy; 2008 Sep; 38(9):1432-50. PubMed ID: 18665842
[TBL] [Abstract][Full Text] [Related]
7. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
Russo GL
Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
[TBL] [Abstract][Full Text] [Related]
8. Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.
Hon G; Hassan M; van Rensburg SJ; Abel S; Marais de W; van Jaarsveld P; Smuts C; Henning F; Erasmus R; Matsha T
Br J Nutr; 2009 Nov; 102(9):1334-40. PubMed ID: 19454128
[TBL] [Abstract][Full Text] [Related]
9. [Polyunsaturated (essential) fatty acids and their importance in pathogenesis, diagnosis and therapy of multiple sclerosis].
Seidel D
Fortschr Neurol Psychiatr; 1982 Jun; 50(6):173-89. PubMed ID: 7118042
[TBL] [Abstract][Full Text] [Related]
10. Essential fatty acids and related molecular and cellular mechanisms in multiple sclerosis: new looks at old concepts.
Mayer M
Folia Biol (Praha); 1999; 45(4):133-41. PubMed ID: 10732726
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of dietetic intervention in multiple sclerosis].
Agnello E; Palmo A
Minerva Gastroenterol Dietol; 2004 Dec; 50(4):317-23. PubMed ID: 15788987
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
Calder PC
Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acids and inflammation.
Calder PC
Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):197-202. PubMed ID: 16828270
[TBL] [Abstract][Full Text] [Related]
14. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease.
Simopoulos AP
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():131-4. PubMed ID: 18296320
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids and nutrition.
Hansen HS; Artmann A
J Neuroendocrinol; 2008 May; 20 Suppl 1():94-9. PubMed ID: 18426507
[TBL] [Abstract][Full Text] [Related]
16. [Fatty diet and multiple sclerosis].
de Andrés C; Lledó A
Rev Neurol; 1997 Dec; 25(148):2032-5. PubMed ID: 9528051
[TBL] [Abstract][Full Text] [Related]
17. The opposing effects of n-3 and n-6 fatty acids.
Schmitz G; Ecker J
Prog Lipid Res; 2008 Mar; 47(2):147-55. PubMed ID: 18198131
[TBL] [Abstract][Full Text] [Related]
18. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial.
Thienprasert A; Samuhaseneetoo S; Popplestone K; West AL; Miles EA; Calder PC
J Pediatr; 2009 Mar; 154(3):391-5. PubMed ID: 18930251
[TBL] [Abstract][Full Text] [Related]
19. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
20. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
